Seelos Therapeutics adopts amended bylaws for universal proxy rules and enhanced disclosure

SEELOS THERAPEUTICS, INC.

Board approved Amended and Restated Bylaws effective March 23, 2023.
Amendments require compliance with SEC Rule 14a-19 universal proxy rules, including notice and solicitation requirements.
Enhanced disclosure requirements for director nominations and stockholder proposals; background info on nominating stockholders and nominees required.
Stockholders cannot nominate more candidates than board seats; Board may require nominee interviews.
Stockholders soliciting proxies must use non-white proxy card; white reserved for Board. Remote meetings allowed.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

SEELOS THERAPEUTICS, INC.: Amended and restated bylaws to address universal proxy rules and enhance disclosure requirements for director nominations and stockholder proposals (effective 2023-03-23).

Change: bylaw amendment
Effective: 2023-03-23

Exact text from the filing

On March 23, 2023, the Board of Directors (the “Board”) of Seelos Therapeutics, Inc. (the “Company”) approved and adopted an amendment and restatement of the Company’s amended and restated bylaws (as so amended and restated, the “Amended and Restated Bylaws”), effective as of such date. The amendments effected by the Amended and Restated Bylaws address the universal proxy rules promulgated by the U.S. Securities and Exchange Commission, as set forth in Rule 14a-19 of the Securities Exchange Act of 1934, as amended (the “1934 Act”).

View on SEC.gov

Browse all governance changes →

Source: SEC EDGAR

accession 0001104659-23-036612

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.